Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

por Wainberg, Z A, Lin, L-S, DiCarlo, B, Dao, K M, Patel, R, Park, D J, Wang, H-J, Elashoff, R, Ryba, N, Hecht, J R
Publicado 2011

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

por Hecht, J.R., Raman, S.S., Chan, A., Kalinsky, K., Baurain, J.-F., Jimenez, M.M., Garcia, M.M., Berger, M.D., Lauer, U.M., Khattak, A., Carrato, A., Zhang, Y., Liu, K., Cha, E., Keegan, A., Bhatta, S., Strassburg, C.P., Roohullah, A.
Publicado 2023